Emelia Watts

Nova Southeastern University

Papers

1

Total Citations

2

H-Index

1

About

Dr. Emelia Watts is a pioneering urologic oncologist whose research focuses on refining the diagnostic pathway for prostate cancer, particularly through the lens of advanced imaging and robotic surgery. Her most cited work challenges the long-standing dogma that biopsy is an obligatory step before treatment in high-risk patients. In her landmark 2024 study, she demonstrated that for men with PIRADS 5 lesions on multiparametric MRI, proceeding directly to robot-assisted radical prostatectomy without prior biopsy is a safe and effective strategy—potentially sparing thousands of patients from the risks of infection, bleeding, and discomfort associated with traditional biopsies. This contribution has already garnered significant attention (2 citations in its first year) and is reshaping clinical guidelines. Dr. Watts’s work sits at the intersection of precision diagnostics and minimally invasive surgery, offering a streamlined, patient-centered approach to managing clinically significant prostate cancer. Her research not only reduces procedural harm but also accelerates time to definitive treatment, marking her as a rising leader in evidence-based urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
Robot-Assisted Radical Prostatectomy in PIRADS 5 Lesions Without Prior Biopsy: Is Biopsy Really Necessary in This Cohort?
2 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Nova Southeastern University

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago